CASSS cultivates a global community
of industry, academic and regulatory professionals to work together to resolve scientific challenges in the field of biopharmaceutical development and regulation.
I want to:
CMC Strategy Forum ChinaAugust 23 to 24, 2022
DC Discussion GroupSeptember 14, 2022
CE in the Biotechnology & Pharmaceutical IndustriesSeptember 18 to 21, 2022
Practical Applications of Mass Spectrometry in the Biotechnology IndustrySeptember 27 to 30, 2022
The Netherlands Area Biotech Discussion GroupOctober 6, 2022
CMC Strategy Forum EuropeOctober 17 to 19, 2022
CMC Strategy Forum JapanDecember 5 to 6, 2022
CMC Strategy Forum North AmericaJanuary 23, 2023
WCBPJanuary 24 to 26, 2023
Bioassays: Scientific Approaches & Regulatory StrategiesApril 17 to 19, 2023
Analytical Technologies EuropeMay 9 to 12, 2023
Latest CASSS News
National Minority Donor Awareness Month
Aug 12, 2022
August is National Minority Donor Awareness Month (NMDAM), when we call attention to the disparities between the number of organ donors and the number of minorities, including African American, Latinx, and Asian Americans, in need of life-saving organs and tissues.
Member Spotlight: Patsy Lewis
Jul 25, 2022
The Member Spotlight is an ongoing Q&A series focused on getting to know the CASSS community. Today’s spotlight shines on Patsy Lewis, Director of CMC Development-Virtual at Tonix Pharmaceuticals.
I attended Cell & Gene Therapy 2022 in person in Arlington. It was a fantastic meeting as always with excellent talks from industry SMEs as well as speakers from regulatory agencies around the globe (FDA, EU, Health Canada, etc),
great opportunity for networking as well. I really enjoyed the meeting.
— Cheng-Hong Wei Cell & Gene Therapy Products 2022